We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04383938
Brief Title: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

First Submitted : May 7, 2020
First Submitted that Met QC Criteria : May 11, 2020
First Posted : May 12, 2020

Last Update Submitted that Met QC Criteria : June 1, 2022
Last Update Posted : June 3, 2022